Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute My... অনুযায়ী Amir T. Fathi (15313195)

অন্যান্য লেখক: “…Haesook T. Kim (15313198)…”

Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute My... অনুযায়ী Amir T. Fathi (15313195)

অন্যান্য লেখক: “…Haesook T. Kim (15313198)…”